Scynexis Inc (SCYX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1 EVERTRUST PLAZA JERSEY CITY, NJ 07302-6548

Scynexis Inc provides pharmaceutical products. The company discovers, develops, and distributes intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans.

Data based on most recent fiscal year report
Market Cap37.985 Million Shares Outstanding28.56 Million Avg Volume531.983 Thousand
1-Yr BETA vs S&P TR0.8 Current Ratio4.43 Quick Ratio4.43
View SEC Filings from SCYX instead.
Q4 2018 All Institutions Hedge Funds 1
To trade SCYX now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 32 5 (0.5%)
Aggregate 13F shares on 12/31/2018: 16.753 Million 1.951 Million
Aggregate 13F shares on 09/30/2018: 19.868 Million 4.776 Million
Percent change: -15.68% -59.16%
Funds creating new positions: 6 1
Funds Adding to an existing position: 4 1
Funds closing out their position: 12 5
Funds reducing their position: 8 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SCYX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MACHADO PATRICK

  • 10% Owner
105,952,381 2019-03-18 1

RIBEILL YVES J

  • Director
40,020 2019-03-11 0

SANOFI

23,523,269 2019-03-08 0

HASTINGS DAVID C CHIEF FINANCIAL OFFICER

  • Officer
0 2019-03-01 1

GILMAN STEVEN C

0 2019-02-28 1

TAGLIETTI MARCO CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-02-15 4

ANGULO GONZALEZ DAVID CHIEF MEDICAL OFFICER

  • Officer
271,790 2019-02-15 4

FRANCOIS ERIC CHIEF FINANCIAL OFFICER

  • Officer
149,917 2019-02-15 1

SUKENICK SCOTT GENERAL COUNSEL

  • Officer
102,959 2019-02-15 1

ANIDO ARMANDO CHAIRMAN & CHIEF EXEC. OFFICER

  • Officer
  • Director
0 2019-01-24 2

MACDONALD GUY PRESIDENT AND CHIEF EXECUTIVE

  • Officer
  • Director
134,396 2019-01-17 4

PENHOET EDWARD

  • Director
0 2019-01-03 0

HANHAM ANN

  • Director
0 2019-01-02 1

MCCOURT MARION SVP COMMERCIAL

  • Officer
12,500 2018-12-12 2

ARTHAUD LAURENT

  • Director
9,800 2017-07-20 0

VENTECH CAPITAL II

  • 10% Owner
1,431,814 2017-03-13 0

LANGLOIS PATRICK

  • Director
0 2017-01-03 0

SABLE CAROLE CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2016-10-25 0

CHAOUI MOUNIA

  • Director
0 2016-03-29 0

WOODALL JONATHAN SEARS INTERIM CHIEF FINANCIALOFFICER

  • Officer
500 2015-07-22 0

KIRBY PAMELA J

  • Director
0 2015-04-01 0

NOTHIAS JEAN-YVES

  • Director
0 2015-04-01 0

OSBORNE, JR. CHARLES F CHIEF FINANCIAL OFFICER

  • Officer
0 2015-04-01 0

PRUETTE EILEEN GENERAL COUNSEL

  • Officer
0 2014-06-18 0

FCPR BIOTECHNOLOGY FUND

  • 10% Owner
No longer subject to file 2014-05-07 0

ALTA BIOPHARMA PARTNERS II LP

ALTA BIOPHARMA MANAGEMENT II LLC

ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC

CHAMPSI FARAH

  • 10% Owner
1,286,311 2014-05-07 0

F.C.P.R. GENAVENT

  • 10% Owner
No longer subject to file 2014-05-07 0

DOELLING VIVIAN W VP OF ANIMAL HEALTH

  • Officer
0 2014-05-02 0

GARRETT MICHAEL C VICE PRESIDENT

  • Officer
3,108 2014-05-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FRANCOIS ERIC - Officer CHIEF FINANCIAL OFFICER

2019-02-15 A 125,000 a 125,000 149,917.00 direct

SUKENICK SCOTT - Officer GENERAL COUNSEL

2019-02-15 A 100,000 a 102,959 102,959.00 direct

ANGULO GONZALEZ DAVID - Officer CHIEF MEDICAL OFFICER

2019-02-15 A 150,000 a 150,000 271,790.00 direct

FRANCOIS ERIC - Officer CHIEF FINANCIAL OFFICER

2019-02-15 A 125,000 a 149,917 149,917.00 direct

TAGLIETTI MARCO - Director - Officer CHIEF EXECUTIVE OFFICER

2019-02-15 A 700,000 a 700,000 0.00 direct

ANGULO GONZALEZ DAVID - Officer CHIEF MEDICAL OFFICER

2019-02-15 A 150,000 a 271,790 271,790.00 direct

SUKENICK SCOTT - Officer GENERAL COUNSEL

2019-02-15 A 100,000 a 100,000 102,959.00 direct

ANIDO ARMANDO - Director

2019-01-21 A 70,000 a 70,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments